Depressed Colorectal Cancer: A New Paradigm in Early Colorectal Cancer.
Adenoma
/ diagnosis
Aged
Biomarkers, Tumor
/ genetics
Carcinoma
/ diagnosis
Colon
/ diagnostic imaging
Colonoscopy
Colorectal Neoplasms
/ diagnosis
DNA Mutational Analysis
Diagnosis, Differential
Epithelial-Mesenchymal Transition
/ genetics
Female
Gene Expression Regulation, Neoplastic
Humans
Intestinal Mucosa
/ diagnostic imaging
Male
Middle Aged
Neoplasm Grading
Neoplasm Invasiveness
/ genetics
Neoplasm Staging
Proto-Oncogene Proteins p21(ras)
/ genetics
RNA-Seq
Exome Sequencing
Journal
Clinical and translational gastroenterology
ISSN: 2155-384X
Titre abrégé: Clin Transl Gastroenterol
Pays: United States
ID NLM: 101532142
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
entrez:
29
1
2021
pubmed:
30
1
2021
medline:
16
7
2021
Statut:
ppublish
Résumé
In contrast to most colorectal carcinomas arising from pedunculated or sessile protruded adenomas, submucosal-invasive (pT1) colorectal carcinoma exhibiting a depressed surface (hereinafter, "depressed colorectal carcinoma," identified by means of high-definition endoscopy) is considered to be derived from depressed precursors. We hypothesized that depressed colorectal neoplasms have unique clinicopathological features different that are different from those of protruded and flat colorectal neoplasms. We classified 27,129 colorectal neoplasms (909 pT1 carcinomas and 26,220 adenomas) resected between 2001 and 2017 into depressed (211 carcinomas and 109 adenomas), flat (304 carcinomas and 11,246 adenomas), and protruded subtypes (394 carcinomas and 14,865 adenomas) and compared their clinicopathological features. As exploratory analyses of pT1 carcinomas, we conducted whole-exome sequencing for 19 depressed and 8 protruded subtypes and RNA sequencing for 8 depressed and 8 protruded subtypes. pT1 carcinomas were more common in depressed lesions (66%) than in protruded (2.6%) and flat lesions (2.6%) (P < 0.001). Compared with nondepressed pT1 carcinomas, depressed pT1 carcinomas were positively correlated with lymphovascular invasion, tumor budding, and massive submucosal invasion and inversely correlated with the presence of an adenoma component (all P < 0.001). Depressed adenomas were more likely to contain high-grade dysplasia than nondepressed adenomas (49% vs 11%, P < 0.001). A KRAS mutation was observed only in one of the 19 depressed pT1 carcinomas. Relative to protruded carcinomas, depressed carcinomas generally exhibited higher expression of genes related to angiogenesis and epithelial-mesenchymal transition. Depressed colorectal neoplasms may harbor a unique combination of malignant histopathological phenotypes and molecular features.
Identifiants
pubmed: 33512809
doi: 10.14309/ctg.0000000000000269
pii: 01720094-202012000-00017
pmc: PMC7732270
doi:
Substances chimiques
Biomarkers, Tumor
0
KRAS protein, human
0
Proto-Oncogene Proteins p21(ras)
EC 3.6.5.2
Types de publication
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e00269Subventions
Organisme : NCI NIH HHS
ID : R35 CA197735
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA230873
Pays : United States
Références
Oncol Rep. 2013 Jul;30(1):350-6
pubmed: 23673484
Genome Res. 2018 Aug;28(8):1111-1125
pubmed: 30012835
Hum Pathol. 1996 Oct;27(10):1042-9
pubmed: 8892588
Gastroenterology. 2017 Sep;153(3):732-742.e1
pubmed: 28583826
Gut. 2011 Mar;60(3):397-411
pubmed: 21036793
N Engl J Med. 2013 Sep 19;369(12):1095-105
pubmed: 24047059
Gut. 2000 Aug;47(2):251-5
pubmed: 10896917
Nat Rev Cancer. 2009 Apr;9(4):265-73
pubmed: 19262571
Nat Rev Cancer. 2017 Feb;17(2):79-92
pubmed: 28050011
Gastroenterology. 2006 Feb;130(2):566-76; quiz 588-9
pubmed: 16472608
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Endosc Int Open. 2017 Dec;5(12):E1284-E1288
pubmed: 29218321
Endoscopy. 1993 Sep;25(7):455-61
pubmed: 8261988
Gastrointest Endosc. 2008 Oct;68(4 Suppl):S3-47
pubmed: 18805238
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
J Gastroenterol Hepatol. 2000 Mar;15 Suppl:D66-70
pubmed: 10759223
Gastrointest Endosc. 2003 Dec;58(6 Suppl):S3-43
pubmed: 14652541
Clin Gastroenterol Hepatol. 2005 Jul;3(7 Suppl 1):S33-6
pubmed: 16012993
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
Nature. 2014 Jan 23;505(7484):495-501
pubmed: 24390350
Gastroenterology. 2004 Aug;127(2):385-94
pubmed: 15300569
Int J Colorectal Dis. 2018 Aug;33(8):1029-1038
pubmed: 29748707
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Dig Endosc. 2015 Mar;27(3):300-2
pubmed: 25754006
Dig Endosc. 2015 May;27(4):417-434
pubmed: 25652022
Endoscopy. 1995 Jan;27(1):54-7; discussion 61
pubmed: 7601037
JAMA. 2008 Mar 5;299(9):1027-35
pubmed: 18319413
Methods Mol Biol. 2014;1150:45-79
pubmed: 24743990
Ann Pathol. 2011 Nov;31(5 Suppl):S27-31
pubmed: 22054452
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Genome Biol. 2011 Aug 11;12(8):R72
pubmed: 21835007
N Engl J Med. 1993 Dec 30;329(27):1977-81
pubmed: 8247072
Int J Clin Oncol. 2018 Feb;23(1):1-34
pubmed: 28349281